Gilead Sciences EPS Basic from Accounting Change (Quarterly) Analysis

Gilead Sciences, Inc. (GILD)

124.91 +3.65 (+3.01%) USD | NASDAQ | Jan 16, 16:00

125.00 +0.09 (+0.07%) After-Hours: 05:42

View EPS Basic from Accounting Change (Quarterly) for GILD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Accounting Change (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Johnson & Johnson	--
Eli Lilly & Co.	--
Merck & Co., Inc.	--
Regeneron Pharmaceuticals, Inc.	--